Quince Therapeutics Inc (QNCX) Profitability Comparisons, Net Margin, Gross Margin, Tax rate, Cash Flow Margin Comparisons - CSIMarket
CSIMarket
 


Quince Therapeutics Inc   (NASDAQ: QNCX)

Quince Therapeutics Inc Profitability Comparisons

Select each Category to receive further Information




QNCX Profitability Ratio

Company Industry Sector S&P 500
Gross Profit Margin (Q2 MRQ) - 69.56 % 54.17 % 38.76 %
Gross Margin (Q2 TTM) - 72.13 % 55.83 % 38.1 %
Gross Profit Margin 5 Yr. Avg. - 64.49 % 52.73 % 32.57 %
EBITDA Margin (Q2 MRQ) - 25.69 % 21.71 % 22.29 %
EBITDA Margin (Q2 TTM) - 32.51 % 23.62 % 20.86 %
EBITDA Margin 5 Yr. Avg. - 26.11 % 34.68 % 23.54 %
Operating Margin (Q2 MRQ) - 11.32 % 16.59 % 16.03 %
Operating Margin (Q2 TTM) - 16.54 % 17.93 % 16.33 %
Operating Margin 5 Yr. Avg. - 9.77 % 14.72 % 16.67 %
Pre-Tax Profit Margin (Q2 MRQ) - 7.43 % 10.94 % 13.95 %
Pre-Tax Profit Margin (Q2 TTM) - 15.1 % 12.85 % 13.1 %
Pre-Tax Profit Margin 5 Yr. Avg. - 9.68 % 10.64 % 12.23 %
Net Margin (Q2 MRQ) - 2.64 % 8.14 % 11.42 %
Net Margin (Q2 TTM) - 11.08 % 9.97 % 10.76 %
Net Margin 5 Yr. Avg. - 5.12 % 6.12 % 9.64 %



Business Segment Profit Margin
 
 

Company's Cashflow Profitability & Other



Profitability Ratios Company Industry Sector S&P 500
Free Cash Flow Margin (Q2 MRQ) - 1.35 % 0.21 % 1.38 %
Free Cash Flow Margin (Q2 TTM) - 17.32 % 13.96 % 9.24 %
Free Cash Flow Margin 5 Yr. Avg. - 15.64 % 15.75 % 13.82 %
Net Cash Flow Margin (Q2 MRQ) - 0.47 % -0.01 % 0.15 %
Net Cash Flow Margin (Q2 TTM) - 4.98 % 0.09 % 1.79 %
Net Cash Flow Margin 5 Yr. Avg. - 10.47 % 3.09 % 5.71 %
Effective Tax Rate (Q2 MRQ)